| For: | Ishibashi Y, Kobayashi H, Ando T, Okajima K, Oki T, Tsuda Y, Shinoda Y, Sawada R, Tanaka S. Prognostic factors in patients with bone metastasis of lung cancer after immune checkpoint inhibitors: A retrospective study. World J Orthop 2024; 15(12): 1155-1163 [PMID: 39744733 DOI: 10.5312/wjo.v15.i12.1155] |
|---|---|
| URL: | https://www.wjgnet.com/2218-5836/full/v15/i12/1155.htm |
| Number | Citing Articles |
| 1 |
Júlio Martins Lopes, Vânia Oliveira, Pedro Cardoso, Manuel Magalhães, Paula Fidalgo, António Araújo. Orthopaedic Management of Bone Metastases from Lung Cancer. Cancers 2026; 18(19) doi: 10.3390/cancers18193228
|
| 2 |
Min Dong, Guili Zheng, Fangyuan Yu, Jiaqi Yin, Chen Zhong. Immune checkpoint inhibition in bone metastases: lesion response heterogeneity, the osteoimmune niche, and microenvironment-directed therapy. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1959101
|